Literature DB >> 17944689

Peripheral arterial disease in HIV-infected and uninfected women.

A Sharma1, S Holman, R Pitts, H L Minkoff, J A Dehovitz, J Lazar.   

Abstract

OBJECTIVE: Although HIV infection has been associated with increased risk of subclinical atherosclerosis and cardiovascular events, peripheral arterial disease (PAD) has not been assessed in HIV-infected patients. The objective of this study was to determine the prevalence of, and risk factors for, PAD using ankle-brachial index (ABI) measurement in HIV-infected and uninfected women.
METHODS: ABI was determined for 335 participants in the Women's Interagency HIV Study (WIHS). A cross-sectional analysis was conducted to determine factors associated with high (>or=1.40) ABI.
RESULTS: The prevalence of low ABI (<or=0.9) was 0.9% (n=3) and the prevalence of high ABI (>or=1.40) was 6.9% (n=23). The prevalence of low ABI was too low to allow risk factor analysis. On multivariate analysis, factors associated with high ABI were current cigarette smoking [adjusted odds ratio (OR(adj)) 2.53, 95% confidence interval (CI) 0.99-6.43], being underweight (OR(adj) 11.0, 95% CI 1.61-75.63) and being overweight (OR(adj) 5.40, 95% CI 1.13-25.89).
CONCLUSIONS: Although the prevalence of ABI <or=0.9 was low in this cohort of HIV-infected and uninfected women, the prevalence of ABI >or=1.40 was unexpectedly high. Further studies are indicated to determine the clinical significance of high ABI and its relation to the risk of cardiovascular events in HIV-infected women.

Entities:  

Mesh:

Year:  2007        PMID: 17944689     DOI: 10.1111/j.1468-1293.2007.00509.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  7 in total

1.  Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population.

Authors:  Alexandra E Teng; Kevin F Kennedy; Rushi V Parikh; Ehrin J Armstrong; Priscilla Y Hsue; Eric A Secemsky
Journal:  AIDS       Date:  2022-07-15       Impact factor: 4.632

Review 2.  HIV and Cardiovascular Disease: Update on Clinical Events, Special Populations, and Novel Biomarkers.

Authors:  Kaku So-Armah; Matthew S Freiberg
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

3.  Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross-sectional study.

Authors:  James J Jang; Aron I Schwarcz; Daniel A Amaez; Mark Woodward; Jeffrey W Olin; Marla J Keller; Alison D Schecter
Journal:  J Int AIDS Soc       Date:  2010-03-22       Impact factor: 5.396

4.  Contributions of HIV, hepatitis C virus, and traditional vascular risk factors to peripheral artery disease in women.

Authors:  Emily Cedarbaum; Yifei Ma; Rebecca Scherzer; Jennifer C Price; Adaora A Adimora; Marcas Bamman; Mardge Cohen; Margaret A Fischl; Kunihiro Matsushita; Igho Ofotokun; Michael Plankey; Eric C Seaberg; Michael T Yin; Carl Grunfeld; Shant Vartanian; Anjali Sharma; Phyllis C Tien
Journal:  AIDS       Date:  2019-11-01       Impact factor: 4.632

5.  Peripheral arterial disease and ankle-brachial index abnormalites in young and middle-aged HIV-positive patients in lower Silesia, Poland.

Authors:  Wiesława Kwiatkowska; Brygida Knysz; Katarzyna Arczyńska; Justyna Drelichowska; Marcin Czarnecki; Jacek Gąsiorowski; Maciej Karczewski; Wojciech Witkiewicz
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

6.  Prevalence and risk factors of peripheral artery disease in black Africans with HIV infection: a cross-sectional hospital-based study.

Authors:  Félicité Kamdem; Yacouba Mapoure; Ba Hamadou; Fanny Souksouna; Marie Solange Doualla; Ahmadou Musa Jingi; Caroline Kenmegne; Fernando Kemta Lekpa; Jaff Kweban Fenkeu; Gisèle Imandy; Jean Pierre Nda Mefo'o; Henry Luma
Journal:  Vasc Health Risk Manag       Date:  2018-12-06

7.  Ankle-brachial index in HIV infection.

Authors:  Julián Olalla; Daniel Salas; Javier de la Torre; Alfonso Del Arco; José Luis Prada; Francisco Martos; Emilio Perea-Milla; Javier García-Alegría
Journal:  AIDS Res Ther       Date:  2009-04-27       Impact factor: 2.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.